Pharmafile Logo
Pharmafocus logo
Advanced Search

CSL vaccine probe likely to rule out manufacturing errors

September 6, 2011
Manufacturing and Production CSL Biotherapies, flu, pharma manufacturing news, vaccines

CSL Biotherapies has said that manufacturing errors were likely not to blame for febrile seizures in children who received its …

News

Pharma manufacturing news in brief

September 6, 2011
Manufacturing and Production pharma manufacturing news

USP expands operations in India, DSM gets green light for Chinese anti-infective joint venture, plus there are updates from CMC …

News
Novartis Afinitor

Afinitor expands European licence

September 5, 2011
Sales and Marketing Afinitor, Novartis, Pancreatic cancer

Novartis’ Afinitor has made further strides in the EU with an approval for use in patients with advanced pancreatic neuroendocrine …

News

NICE rejects three bowel cancer drugs

September 5, 2011
Sales and Marketing Erbitux, NICE, Vectibix, avastin, colorectal cancer

NICE says three treatments – Roche’s Avastin, Merck KgAa’s Erbitux and Amgen’s Vectibix – are all not cost effective in …

News
Boehringer-Lilly's Trajenta

Boehringer-Lilly won’t launch Trajenta in Germany

September 5, 2011
Sales and Marketing Drug pricing, Germany, Tradjenta, Trajenta, price cuts

Boehringer Ingelheim and Lilly have decided not to launch their new diabetes drug Trajenta in Germany and say the country’s …

News
AstraZeneca's Crestor (rosuvastatin)

Crestor fails head-to-head test against Lipitor

September 2, 2011
Sales and Marketing Crestor, Lipitor

AstraZeneca’s cholesterol drug Crestor has failed to show it can stop artery disease better than Pfizer’s Lipitor. The new study …

News

Philippines pricing controls: Pfizer ‘considered taking drugs off the market’

September 2, 2011
Sales and Marketing Drug pricing, Philippines, price cuts

Pfizer considered withdrawing some of its products from the Philippines rather than face planned pricing controls, according to a US …

News

Zonegran study could pave way for paediatric licence

September 2, 2011
Research and Development, Sales and Marketing Eisai, Zonegran, epilepsy, research and development news

Eisai’s epilepsy drug Zonegran has been found more effective than placebo in children with the neurological condition who have seizures. …

News

Robert Yates appointed president of Millipore

September 2, 2011
Sales and Marketing appointment, sales and marketing

Merck KGaA has appointed diagnostics expert Robert Yates to the newly-created role of president at Millipore, the company it acquired …

Appointment
smartphone

Digital Pharma: Mobile marketing

September 1, 2011
Medical Communications Digital Pharma blog, iphone, mobile, smart devices

“This, is not a phone,” said Mark Blayney Stuart holding up his BlackBerry. “It’s a very powerful computer that happens …

Feature
Pfizer Sandwich Kent

Ex-Pfizer employees set up new business at Sandwich

September 1, 2011
Research and Development Pfizer, Sandwich, The Research Network, research and development news

Seven former Pfizer employees have set up a new business in Sandwich that will provide outsourcing services for the pharma …

News

Stem cell trial for stroke is safe

September 1, 2011
Research and Development ReNeuron, Stem cells, stroke

A pioneering stem cell treatment for patients who have suffered a stroke has been ruled safe, and can continue to …

News
rich_baptista

Rich Baptista joins Synergy Vision

September 1, 2011
Medical Communications London, Quintiles, agency, appointment, chiltern, comms, communications, creativity, digital, excellence, innovation, leader, leadership, marketing, med, medical, medical communcations, success

London-based medical communications agency Synergy Vision has appointed Rich Baptista as strategic alliance director with a brief to focus on …

Appointment
Roche's Tarceva (erlotinib)

Tarceva approval for first-line use in EGFR lung cancer

September 1, 2011
Sales and Marketing NSCLC, Roche, Tarceva

Tarceva has been granted final European approval for patients with a genetically distinct type of non-small cell lung cancer (NSCLC). …

News

Shire’s Firazyr gains US approval after initial setback

September 1, 2011
Sales and Marketing FDA, Firazyr, Shire

After three years of waiting Shire’s Firazyr has been approved by the FDA for sudden attacks of swelling. The US …

News

Merck acquires cell imaging instrument maker Amnis

September 1, 2011
Research and Development Merck KGaA, Millipore

EMD Millipore, the Massachussetts-based life sciences arm of Merck KGaA, has bought US cell imaging instrument maker Amnis Corporation for …

News

Boehringer expands afatinib breast cancer trials

August 31, 2011
Research and Development Boehringer, afatinib

Boehringer Ingelheim has begun two new phase II trials of its investigational cancer drug afatinib. The studies will cover afatinib’s …

News

FDA wants more information on Novartis arthritis drug

August 31, 2011
Sales and Marketing FDA, Ilaris, Novarits, canakinumab

The FDA has asked Novartis for more information on its gouty arthritis drug canakinumab. The regulator’s request came in a …

News
Boehringer Ingelheim

Pradaxa and Eliquis gain trial boost over warfarin

August 31, 2011
Sales and Marketing Eliquis, Pradaxa, Xarelto, apixaban

A pair of new blood thinners are superior to warfarin when it comes to reducing the risk of stroke in …

News

Nurofen Plus recall expanded

August 31, 2011
Sales and Marketing MHRA, Nurofen, recalls

Last week’s recall of Reckitt Benckiser’s painkiller product Nurofen Plus has been expanded after two additional cases emerged where powerful …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026